Global Pharmaceutical Grade USP L-Glutamine Market Growth 2025-2031
Description
The global Pharmaceutical Grade USP L-Glutamine market size is predicted to grow from US$ 70.8 million in 2025 to US$ 87.7 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
L-Glutamine (commonly abbreviated as Gln) is a conditionally essential amino acid that plays a pivotal role in numerous physiological functions, including protein synthesis, immune response, and gut health. Structurally classified among the 20 standard amino acids, L-Glutamine contains an amide group derived from glutamic acid. It is the most abundant free amino acid in the human body, primarily synthesized in skeletal muscles and transported via the bloodstream to various tissues that require it for metabolic processes. L-Glutamine is deemed conditionally essential because, under normal circumstances, the body produces adequate amounts. However, during times of physical stress, such as trauma, surgery, infection, or intense exercise, the demand for L-Glutamine can exceed the body’s capacity to produce it, necessitating external supplementation.
In commercial form, L-Glutamine is typically produced via microbial fermentation, most commonly using genetically modified strains of bacteria such as Corynebacterium glutamicum or Escherichia coli. The industrial process involves fermenting carbohydrates such as glucose or molasses, followed by purification steps to isolate the amino acid. L-Glutamine is usually available in powdered form but can also be found in capsules, tablets, and functional food products such as protein shakes and fortified bars.
The primary applications of L-Glutamine are found in nutraceuticals, clinical nutrition, sports supplements, functional foods, and animal feed additives. In the field of medicine, L-Glutamine is utilized for its therapeutic benefits in treating conditions such as short bowel syndrome, Crohn’s disease, and to mitigate the side effects of chemotherapy.
Pharmaceutical Grade USP L-Glutamine refers to the purified form of the amino acid L-glutamine.
The global Pharmaceutical Grade USP L-Glutamine market has witnessed steady growth over the past decade, driven by increasing health consciousness and heightened demand for immune-boosting products in the wake of the COVID-19 pandemic. The North American and Asia-Pacific regions dominate the market, with Europe following closely behind.
The use of Pharmaceutical Grade USP L-Glutamine in medical nutrition therapy is major growth driver. Hospitals and clinical settings use glutamine supplementation in enteral and parenteral nutrition for patients suffering from trauma, burns, or gastrointestinal disorders. Additionally, Pharmaceutical Grade USP L-Glutamine has shown promising results in reducing mucositis in cancer patients undergoing chemotherapy or radiation therapy.
As healthcare systems worldwide move from treatment-centric to prevention-centric models, there has been a noticeable rise in demand for functional foods and dietary supplements. Pharmaceutical Grade USP L-Glutamine fits into this trend due to its broad application across multiple wellness domains, including digestive health, metabolic health, and immune modulation.
Global Pharmaceutical Grade USP L-Glutamine core manufacturers include Ajinomoto, Kyowa Hakko Kirin, Daesang, Meihua and Fufeng, etc. The top three manufacturers account for approximately 75% of the global share. The United States is the world's largest market, accounting for nearly 40% of the market.
LP Information, Inc. (LPI) ' newest research report, the “Pharmaceutical Grade USP L-Glutamine Industry Forecast” looks at past sales and reviews total world Pharmaceutical Grade USP L-Glutamine sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Grade USP L-Glutamine sales for 2025 through 2031. With Pharmaceutical Grade USP L-Glutamine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Grade USP L-Glutamine industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Grade USP L-Glutamine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Grade USP L-Glutamine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Grade USP L-Glutamine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Grade USP L-Glutamine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Grade USP L-Glutamine.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Grade USP L-Glutamine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Purity ＜99%
Purity ≥99%
Segmentation by Application:
Digestive Health
Metabolic Health
Immune Modulation
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
MeiHua Holdings Group
Ajinomoto
Kyowa Hakko
Fufeng Group
Daesang
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pharmaceutical Grade USP L-Glutamine market?
What factors are driving Pharmaceutical Grade USP L-Glutamine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Grade USP L-Glutamine market opportunities vary by end market size?
How does Pharmaceutical Grade USP L-Glutamine break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
L-Glutamine (commonly abbreviated as Gln) is a conditionally essential amino acid that plays a pivotal role in numerous physiological functions, including protein synthesis, immune response, and gut health. Structurally classified among the 20 standard amino acids, L-Glutamine contains an amide group derived from glutamic acid. It is the most abundant free amino acid in the human body, primarily synthesized in skeletal muscles and transported via the bloodstream to various tissues that require it for metabolic processes. L-Glutamine is deemed conditionally essential because, under normal circumstances, the body produces adequate amounts. However, during times of physical stress, such as trauma, surgery, infection, or intense exercise, the demand for L-Glutamine can exceed the body’s capacity to produce it, necessitating external supplementation.
In commercial form, L-Glutamine is typically produced via microbial fermentation, most commonly using genetically modified strains of bacteria such as Corynebacterium glutamicum or Escherichia coli. The industrial process involves fermenting carbohydrates such as glucose or molasses, followed by purification steps to isolate the amino acid. L-Glutamine is usually available in powdered form but can also be found in capsules, tablets, and functional food products such as protein shakes and fortified bars.
The primary applications of L-Glutamine are found in nutraceuticals, clinical nutrition, sports supplements, functional foods, and animal feed additives. In the field of medicine, L-Glutamine is utilized for its therapeutic benefits in treating conditions such as short bowel syndrome, Crohn’s disease, and to mitigate the side effects of chemotherapy.
Pharmaceutical Grade USP L-Glutamine refers to the purified form of the amino acid L-glutamine.
The global Pharmaceutical Grade USP L-Glutamine market has witnessed steady growth over the past decade, driven by increasing health consciousness and heightened demand for immune-boosting products in the wake of the COVID-19 pandemic. The North American and Asia-Pacific regions dominate the market, with Europe following closely behind.
The use of Pharmaceutical Grade USP L-Glutamine in medical nutrition therapy is major growth driver. Hospitals and clinical settings use glutamine supplementation in enteral and parenteral nutrition for patients suffering from trauma, burns, or gastrointestinal disorders. Additionally, Pharmaceutical Grade USP L-Glutamine has shown promising results in reducing mucositis in cancer patients undergoing chemotherapy or radiation therapy.
As healthcare systems worldwide move from treatment-centric to prevention-centric models, there has been a noticeable rise in demand for functional foods and dietary supplements. Pharmaceutical Grade USP L-Glutamine fits into this trend due to its broad application across multiple wellness domains, including digestive health, metabolic health, and immune modulation.
Global Pharmaceutical Grade USP L-Glutamine core manufacturers include Ajinomoto, Kyowa Hakko Kirin, Daesang, Meihua and Fufeng, etc. The top three manufacturers account for approximately 75% of the global share. The United States is the world's largest market, accounting for nearly 40% of the market.
LP Information, Inc. (LPI) ' newest research report, the “Pharmaceutical Grade USP L-Glutamine Industry Forecast” looks at past sales and reviews total world Pharmaceutical Grade USP L-Glutamine sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Grade USP L-Glutamine sales for 2025 through 2031. With Pharmaceutical Grade USP L-Glutamine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Grade USP L-Glutamine industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Grade USP L-Glutamine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Grade USP L-Glutamine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Grade USP L-Glutamine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Grade USP L-Glutamine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Grade USP L-Glutamine.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Grade USP L-Glutamine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Purity ＜99%
Purity ≥99%
Segmentation by Application:
Digestive Health
Metabolic Health
Immune Modulation
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
MeiHua Holdings Group
Ajinomoto
Kyowa Hakko
Fufeng Group
Daesang
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pharmaceutical Grade USP L-Glutamine market?
What factors are driving Pharmaceutical Grade USP L-Glutamine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Grade USP L-Glutamine market opportunities vary by end market size?
How does Pharmaceutical Grade USP L-Glutamine break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
81 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Pharmaceutical Grade USP L-Glutamine by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Pharmaceutical Grade USP L-Glutamine by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
